2 ASX 200 healthcare shares to grab for 'attractive outlook'

Australia's health industry has a lot going for it, so take note of these experts' stock tips.

| More on:
A telehealth doctor at her desk.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The healthcare sector is expected to do well in the coming period for multiple reasons.

In the short term, the health industry will enjoy resilient patronage through a depressed economy and a resurgence in activity after the COVID-19 pandemic. 

In the long run, the ageing population in most of the developed world means increased demand for healthcare solutions and services.

So in this spirit, here are two S&P/ASX 200 Index (ASX: XJO) healthcare shares that are recommended as buys this week:

'Sizable market share opportunities'

Sequoia Wealth Management senior wealth manager Peter Day likes the look of respiratory devices maker ResMed CDI (ASX: RMD).

Its share price has climbed almost 10% so far this year. But it has cooled off in excess of 7% since the start of the month, to perhaps present a buying opportunity.

"ResMed makes medical devices to treat sleep-disordered breathing," Day told The Bull.

"Our analysis highlights potential for industry device volume growth, with [sizable] market share opportunities."

Already the business performance has impressed.

"The company increased revenue by 29% in the third quarter of fiscal year 2023 when compared to the prior corresponding period," said Day.

"ResMed's growth outlook is attractive."

Indeed, Day's peers largely agree with him.

According to CMC Markets, 19 out of 26 analysts currently rate RedMed shares as a buy. Fifteen of them consider it a strong buy.

'Appealing entry point' for boom stock

Seneca Financial Solutions investment advisor Tony Langford's pick is Ramsay Health Care Ltd (ASX: RHC).

The Ramsay stock price has plunged 17% since 11 April.

"The shares offer an appealing entry point," said Langford.

The latest numbers out of the private hospital operator were bullish.

"Total revenue of $11.242 billion for the nine months ending March 31, 2023 was up 10.9% on the prior corresponding period," Langford said.

"Earnings before interest and tax of $750.9 million were up 10.5%."

He is happy to buy Ramsay shares now with all the tailwinds seemingly in place. The stock even pays out a 1.7% dividend yield.

"Increasing revenue reflected growth in surgical admissions, a recovery in non-surgical admissions and contributions from acquisitions."

Motley Fool contributor Tony Yoo has positions in ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Broker Notes

5 ASX All Ords shares upgraded to 'strong buy' consensus ratings

Brokers upgraded their ratings on these ASX All Ords stocks last month.

Read more »

A couple cheers as they sit on their lounge looking at their laptop and reading about the rising Redbubble share price
Broker Notes

2 more of the best ASX 200 shares to buy in February

The broker is feeling very bullish about these shares. Let's see what it is saying.

Read more »

A man sits in casual clothes in front of a computer amid graphic images of data superimposed on the image, as though he is engaged in IT or hacking activities.
Technology Shares

2 ASX tech stocks to buy during an anticipated 15% to 20% sector pullback in 2025

Expert reveals 2 of his favourite tech stocks and at what prices we should buy them during a dip.

Read more »

Successful group of people applauding in a business meeting and looking very happy.
Broker Notes

Bell Potter names the best ASX 200 shares to buy in February

The broker believes these shares could generate big returns for investors.

Read more »

Investor sitting in front of multiple screens watching share prices
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A couple sits on a sofa, each clutching their heads in horror and disbelief, while looking at a laptop screen.
Broker Notes

5 ASX 200 stocks that could negatively surprise during earnings season

Warning bells are ringing for analysts at Goldman Sachs this earnings season.

Read more »

Excited couple celebrating success while looking at smartphone.
Broker Notes

Guess which ASX 200 stock Bell Potter just upgraded

Let's see why the broker is feeling bullish about this stock.

Read more »

A woman stands at her desk looking a her phone with a panoramic view of the harbour bridge in the windows behind her with work colleagues in the background.
Broker Notes

2 Australian stocks to buy with $5,000 after the market selloff

Analysts are tipping these shares to deliver big returns for investors.

Read more »